Recommended Topic Related To:

Naprelan

"Feb. 11, 2013 -- If you're searching for a new car, a new house, or a new TV, you'll likely compare prices. If you're in the market for a new hip, though, that might not be easy, according to a study published online in JAMA Internal Medicine.

"...

Naprelan

Indications
Dosage
How Supplied

INDICATIONS

Carefully consider the potential benefits and risks of NAPRELAN® (naproxen sodium) Tablets and other treatment options before deciding to use NAPRELAN® (naproxen sodium) Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

NAPRELAN® (naproxen sodium) Tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. It is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea.

DOSAGE AND ADMINISTRATION

Carefully consider the potential benefits and risks of NAPRELAN® (naproxen sodium) and other treatment options before deciding to use NAPRELAN® (naproxen sodium) . Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

After observing the response to initial therapy with NAPRELAN® (naproxen sodium) , the dose and frequency should be adjusted to suit an individual patient's needs.

For the relief of:

Rheumatoid Arthritis, Osteoarthritis, And Ankylosing Spondylitis

The recommended starting dose of NAPRELAN® (naproxen sodium) Tablets in adults is two NAPRELAN® (naproxen sodium) 375 mg tablets (750 mg) once daily, or two NAPRELAN® (naproxen sodium) 500 mg tablets (1000 mg) once a daily. Patients already taking naprozen 250 mg, 375 mg, or 500mg twice daily (morning and evening) may have their total daily dose replaced with NAPRELAN® (naproxen sodium) Tablets as a single daily dose.

During long-term administration, the dose of NAPRELAN® (naproxen sodium) Tablets may be adjusted up or down depending on the clinical response of the patient. In patients who tolerate lower doses of NAPRELAN® (naproxen sodium) Tablets well, the dose may be increased to three NAPRELAN® (naproxen sodium) 500 mg tablets (1500 mg) once daily for limited periods when a higher level of anti-inflammatory/analgesic activity is required. When treating patients, especially at the higher dose levels, the physician should observe sufficient increased clinical benefit to offset the potential increased risk (see CLINICAL PHARMACOLOGY). The lowest effective dose should be sought and used in every patient. Symptomatic improvement in arthritis usually begins within one week; however, treatment for two weeks may be required to achieve a therapeutic benefit. A lower dose should be considered in patients with renal or hepatic impairment or in elderly patients (see PRECAUTIONS). Studies indicate that although total plasma contcentration of naproxen is unchanged, the unbound plasma fraction of naproxen is increased in the elderly. Caution is advised when high doses are required and some adjustment of dosage may be required in elderly patients. As with other drugs used in the elderly it is prudent to use the lowest effective dose.

Management Of Pain, Primary Dysmenorrhea, And Acute Tendinitis And Bursitis

The recommended starting dose is two NAPRELAN® (naproxen sodium) 500 mg tablets (1000 mg) once daily. For patients requiring greater analgesic benefit, three NAPRELAN® (naproxen sodium) 500 mg tablets (1500 mg) may be used for a limited period. Thereafter, the total daily dose should not exceed two NAPRELAN® (naproxen sodium) 500 mg tablets (1000 mg).

Acute Gout

The recommended dose on the first day is two to three NAPRELAN® (naproxen sodium) 500 mg tablets (1000 - 1500 mg) once daily, followed by two NAPRELAN® (naproxen sodium) 500 mg tablets (1000 mg) once daily, until the attack has subsided.

HOW SUPPLIED

NAPRELAN® (naproxen sodium) Controlled-Release Tablets are available as follows:

NAPRELAN® (naproxen sodium) 375: white, capsule-shaped tablet with “N” on one side and “375” on the reverse; in bottles of 100; NDC 68453-375-10. Each tablet contains 412.5 mg naproxen sodium equivalent to 375 mg naproxen.

NAPRELAN® (naproxen sodium) 500: white, capsule-shaped tablet with “N” on one side and “500” on the reverse; in bottles of 75; NDC 68453-850-75. Each tablet contains 550 mg naproxen sodium equivalent to 500 mg naproxen.

Store at controlled room temperature, 20° - 25° C (68° - 77° F). Dispense in a well-closed container.

*Registered Trademark of Elan Corporation plc
**Registered Trademark of Elan Pharma Int. Ltd.
***Naprosyn®is a registered trademark of Syntex Puerto Rico, Inc.

Distributed by: Victory Pharma, Inc., San Diego, CA 92130. Distributed for: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701 Stat-Trade Inc., Morrisville, PA 19067. Manufactured by: Elan Pharma International Ltd., Athlone, Ireland. FDA rev date: 5/29/2007

Last reviewed on RxList: 12/14/2007
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Arthritis

Get the latest treatment options